Long-term follow-up data for daraxonrasib monotherapy in second line metastatic pancreatic ductal adenocarcinoma reinforces promising clinical ...

A panelist discusses how this is an exciting time for pancreatic cancer treatment with the development of RAS inhibitors ...

The diagnostic imaging product 203 Pb-RMX-VH-PIB is an agent that targets the Low-Density Lipoprotein Receptor (LDLR), which is overexpressed in solid tumors such as in GBM and PDAC. In preclinical ...

Revolution Medicines (Nasdaq: RVMD) said Tuesday that it is advancing daraxonrasib into Phase III testing for pancreatic ...

Revolution Medicines, Inc. shares surged on strong Phase 1 data for daraxonrasib in metastatic pancreatic cancer. Click here ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

These insights may inform personalized treatment strategies in which microbiome composition could serve as a biomarker to guide therapy selection,” the researchers wrote.

From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups, according to a study published online April 14 in JAMA Network Open. Arvind ...

EUS was developed in the 1980s to improve the imaging of the pancreas. Traditional transabdominal ultrasound imaging of the pancreas is hampered by intervening bowel gas, bone, and fat. By placing a ...

Bizengri received FDA approval for NSCLC and pancreatic adenocarcinoma with NRG1 gene fusion after prior therapy failure. The eNRGy study showed a 33% ORR in NSCLC and 40% in pancreatic adenocarcinoma ...

DENVER & SAN DIEGO--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients ...

Exposure to pesticides is associated with an increased risk for pancreatic adenocarcinoma, according to two French studies presented at the Francophone Days of Hepatology, Gastroenterology, and ...